Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 1:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2041–2064 of 196,761 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: ALL Clear all

Conditions: Acute Myocardial Infarction
Interventions: Atorvastatin calcium, Inactive Placebo; Drug
Lead sponsor: The Western Pennsylvania Hospital; Other
Eligibility: 25 Years to 90 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania

Conditions: Diabetic Macular Edema
Interventions: Intravitreal Aflibercept; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Nicotine Dependence
Interventions: Smoking Cessation Counseling; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Osteomyelitis
Interventions: Hitachi-Aloka Noblus ultrasound scanner, Magnetic Resonance Imaging (MRI); Device
Lead sponsor: Calvary Hospital, Bronx, NY; Other
Eligibility: 18 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Asthma
Interventions: Maintenance Phase Intervention; Behavioral
Lead sponsor: Sinai Health System; Other
Eligibility: 18 Years and older
Enrollment: 143 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Gambling
Interventions: 10 minutes of psycho-education, 10 minutes of brief advice, four 50-minute individual therapy sessions of MET & CBT; Behavioral
Lead sponsor: UConn Health; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Health Diagnostic Laboratory, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 3
States / cities: Camp Hill, Pennsylvania • Ephrata, Pennsylvania • Lancaster, Pennsylvania

Conditions: Cancer, Health Promotion
Interventions: Interactive Preventive Health Record; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 3
States / cities: Albuquerque, New Mexico • Portland, Oregon • Richmond, Virginia

Conditions: Hepatocellular Carcinoma
Interventions: mapatumumab, sorafenib; Biological · Drug
Lead sponsor: Human Genome Sciences Inc., a GSK Company; Industry
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 6
States / cities: Los Angeles, California • Aurora, Colorado • Gainesville, Florida + 3 more

Conditions: Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Interventions: Ibrutinib; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Asthma
Interventions: Intervention; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 12 Years to 15 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Infection, Precancerous Condition
Interventions: Gardasil; Biological
Lead sponsor: AIDS Malignancy Consortium; Network
Eligibility: 18 Years and older · Male only
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 8
States / cities: Los Angeles, California • San Francisco, California • Denver, Colorado + 4 more

Conditions: Gingival Overgrowth
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 2 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cachexia; Cancer, Weight Loss, Lung Cancer, Gastrointestinal Cancer
Interventions: Remune, EXCAP©®; Drug · Other
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Atrial Fibrillation
Interventions: Electrocardiogram; Diagnostic Test
Lead sponsor: Fitbit LLC; Industry
Eligibility: 22 Years and older
Enrollment: 472 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 9
States / cities: Washington D.C., District of Columbia • Orlando, Florida • The Villages, Florida + 6 more

Conditions: Neurofibromatosis 1, Neurofibroma, Atypical Neurofibroma, Atypical Neurofibromatosis, Plexiform Neurofibroma, Von Recklinghausen Disease
Interventions: Whole Body MRI; Diagnostic Test
Lead sponsor: Children's National Research Institute; Other
Eligibility: 8 Years to 30 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Bone Tumor, Osteoporosis, Traumatic Fracture
Interventions: Percutaneous procedure in the MSK structures of the pelvis and/or the spine; Device
Lead sponsor: Precision IO Group; Industry
Eligibility: 22 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: San Diego, California • Miami, Florida • Chicago, Illinois

Conditions: Soft Tissue Sarcoma (STS)
Interventions: 5-ALA; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Hemorrhoid Pain
Interventions: deep breathing exercises; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV Infections, Tuberculosis
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 1 Day and older
Enrollment: 1,509 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1992 – 1994
U.S. locations: 13
States / cities: Denver, Colorado • Washington D.C., District of Columbia • Chicago, Illinois + 8 more

Conditions: Bladder Cancer
Interventions: Mitomycin C, Chemophase; Drug
Lead sponsor: Halozyme Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 5
States / cities: Phoenix, Arizona • La Mesa, California • Gainesville, Florida + 2 more

Conditions: Obesity
Interventions: 24-hour energy expenditure and substrate utilization; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 65 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Kannapolis, North Carolina

Conditions: Atrial Fibrillation
Interventions: Warfarin, Dabigatran; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 78,140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Depression, Involutional, Major Depresssion
Interventions: Yohimbine hydrochloride, Placebo; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

To Investigate the Role of Upstream High Dose Statin in STEMI

A Pharmacokinetic stuDy of intRavitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema

Brain Activity and Smoking Cessation

Detection of Osteomyelitis Using High Resolution Ultrasound

Helping Chicago's Westside Adults Breathe and Thrive

Brief Therapies for Problem Gambling Substance Abusers

Cardiometabolic Risk in Cardiac Rehab

Implementing Personal Health Records to Promote Evidence-Based Cancer Screening

A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma

Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)

A Pilot Study to Improve Preventive Asthma Care for Urban Adolescents

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Genes Associated With Hereditary and Drug-Induced Gingival Overgrowth

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia

Validation of Software for Assessment of Atrial Fibrillation From Data Acquired by a Wearable Smartwatch

Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1

U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures

5-AminoLevulinic Acid Aided Resection Margins in Sarcoma

Post Hemorrhoidectomy Anorectal Pain

A Registry of Tuberculosis Cases in the CPCRA

Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer

Impact of Black Pepper on Energy Expenditure and Substrate Utilization

Replication of the RELY Anticoagulant Trial in Healthcare Claims Data

Rapid Antidepressant Effects of Yohimbine in Major Depression